Recombinant Human EMILIN1 Protein，His

EMILIN1, or Elastin Microfibril Interfacer 1, is a glycoprotein that plays a critical role in the extracellular matrix, primarily influencing the organization and elasticity of connective tissues. It is known to interact with elastin and other structural proteins, contributing to vascular stability and tissue integrity. Research has shown that EMILIN1 is involved in various biological processes, including angiogenesis, tissue remodeling, and inflammation. Abnormal expression of EMILIN1 has been linked to several pathological conditions, such as cardiovascular diseases, fibrotic disorders, and tumors. The characterization of recombinant EMILIN1 protein has gained interest in the scientific community for its potential therapeutic applications and as a biomarker for disease progression. Recombinant protein technology allows for the production of EMILIN1 in controlled environments, ensuring high purity and bioactivity, which can facilitate studies on its molecular functions, interactions, and regulatory mechanisms. By investigating the properties of recombinant EMILIN1, researchers aim to enhance our understanding of its role in health and disease, paving the way for novel strategies in disease treatment and prevention. This focus on EMILIN1 highlights the essential interplay between the extracellular matrix components and cellular behaviors, emphasizing the importance of this protein in maintaining cardiovascular health and potential implications in regenerative medicine. Therefore, the study of EMILIN1 not only provides insights into fundamental biological processes but also holds promise for developing innovative therapeutic approaches targeting various diseases linked to extracellular matrix dysfunction.